Midodrine Tillomed (Midodrine Hydrochloride)

Midodrine is a pro‑drug that is converted to desglymidodrine, which selectively activates peripheral alpha‑1 adrenergic receptors. This activation causes blood vessels to constrict, increasing systemic vascular resistance and raising arterial pressure, especially when a person stands up.

The dose of Midodrine Tillomed is individualized by the prescribing clinician based on the patient’s blood‑pressure response and tolerability. The prescriber determines the appropriate strength, frequency, and timing to achieve the desired therapeutic effect while minimizing side effects.

The safety of Midodrine in pregnancy and lactation has not been fully established, and the product label lists the pregnancy category as unknown. Clinicians should weigh potential benefits against possible risks and consider alternative therapies when treating pregnant or nursing patients.

To order Midodrine Tillomed, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Midodrine is an oral alpha‑1 agonist that directly raises vascular tone, whereas other options such as fludrocortisone increase blood volume, and non‑pharmacologic measures focus on compression garments and fluid intake. Midodrine’s rapid onset makes it useful for patients needing prompt symptom relief, but it requires monitoring for supine hypertension.

Midodrine Tillomed tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. No refrigeration is required, and the product should be kept out of reach of children.

Midodrine Tillomed is taken orally, usually with a full glass of water. It is commonly prescribed to be taken during the day, with the last dose at least four hours before bedtime to reduce the risk of supine hypertension.

The most serious risks include severe supine hypertension, which can lead to cardiovascular complications, and rare cases of myocardial infarction or ischemic events. Patients should be educated to monitor blood pressure while lying down and report any chest pain or unusual symptoms promptly.

Midodrine is contraindicated in patients with severe organic heart disease, acute renal failure, or known hypersensitivity to the drug. It should also be avoided in individuals who have experienced uncontrolled hypertension while supine, as the medication can exacerbate this condition.